Mylan, U.S. finalize $465 million EpiPen settlement

by reuter.com
http://ift.tt/pnED7n
BOSTON (Reuters) - Mylan NV has finalized a $465 million settlement with the U.S. Justice Department resolving claims it overcharged the government for its EpiPen emergency allergy treatment, which became the center of a firestorm over price increases.

Read more

Share on Facebook Share on Twitter Share on Google Plus

About New

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.